From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change. Cohen JB, Jones DW, Flack JM. Circulation 2026;153:137-139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cohen JB, Jones DW, Flack JM. From Race-Based to Equity-Informed Antihypertensive Medication Selection: Rationale for the 2025 AHA/ACC Guideline Change. Circulation 2026;153:137-139.
PMID: 41557778